Godrej Agrovet Limited (GAVL) has announced its financial results for the fourth quarter and full year ended March 31, 2026, showcasing robust growth in both revenue and profitability. The company reported a consolidated revenue from operations of ₹10,233 crore for FY26, marking an increase from ₹9,383 crore in FY25. Profit before tax, excluding non-recurring and exceptional items, rose to ₹569 crore, up from ₹485 crore in the previous year.
In the fourth quarter of FY26, Godrej Agrovet achieved a consolidated revenue from operations of ₹2,333 crore, compared to ₹2,134 crore in the same period last year. The profit before tax for the quarter, excluding non-recurring and exceptional items, was ₹87 crore, an improvement from ₹74 crore in Q4 FY25.
Sunil Kataria, Chief Executive Officer and Managing Director of Godrej Agrovet Limited, highlighted the company’s strategic focus on value-added portfolios and disciplined execution as key drivers of growth. The company reported significant progress in its Oil Palm and Animal Nutrition businesses, with the Oil Palm segment experiencing strong volume growth and margin expansion. The Animal Nutrition segment saw a volume growth of approximately 12% year-on-year, driven by a robust 18% increase in cattle feed.
Astec LifeSciences, a subsidiary of Godrej Agrovet, achieved a turnaround in FY26, reaching EBITDA break-even with improved volumes and higher capacity utilisation. The Dairy business, despite challenges from unseasonal rains and elevated milk procurement prices, showed resilience with a 5% growth in revenues excluding bulk products.
The company also made strides in sustainability, retaining CDP Leadership with an “A–” rating and reducing Scope 1 and 2 emissions by 12.4%. Astec LifeSciences earned EcoVadis Gold, placing it among the top 5% of companies globally.
Godrej Agrovet’s strategic shift towards branded businesses in its Poultry & Processed Foods segment resulted in improved earnings quality, with branded revenue salience exceeding 80% in FY26.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).